Nephros, Inc. (NEPH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NEPH Revenue Growth
Revenue Breakdown (FY 2025)
NEPH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
NEPH Revenue Analysis (2014–2025)
As of May 8, 2026, Nephros, Inc. (NEPH) generated trailing twelve-month (TTM) revenue of $19.1 million, reflecting solid growth of +6.9% year-over-year. The most recent quarter (Q1 2026) recorded $5.2 million in revenue, up 10.2% sequentially.
Looking at the longer-term picture, NEPH's 5-year compound annual growth rate (CAGR) stands at +17.0%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $18.8 million in 2025, representing a new all-time high.
Revenue diversification analysis shows NEPH's business is primarily driven by Royalty and Other Revenues (51%), Service (47%), and Other Revenue (2%). With over half of revenue concentrated in Royalty and Other Revenues, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CNMD (+4.4% YoY), NVCR (+8.5% YoY), and ANGO (+7.3% YoY), NEPH has underperformed the peer group in terms of revenue growth. Compare NEPH vs CNMD →
NEPH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NEPHCurrent | $19M | +6.9% | +17.0% | 6.1% | |
 CNMD | $1.4B | +4.4% | +9.8% | 10.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% | |
 NX | $1.8B | +28.4% | +16.6% | -10.6% | |
 FELE | $2.1B | +8.0% | +11.3% | 12.7% |
NEPH Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $18.8M | +32.7% | $11.5M | 61.1% | $1.1M | 6.1% |
| 2024 | $14.2M | -0.5% | $8.7M | 61.6% | $6K | 0.0% |
| 2023 | $14.2M | +42.7% | $8.4M | 59.0% | $-1,593,000 | -11.2% |
| 2022 | $10.0M | -2.4% | $4.7M | 47.4% | $-4,335,000 | -43.5% |
| 2021 | $10.2M | +19.3% | $5.6M | 55.1% | $-3,252,000 | -31.8% |
| 2020 | $8.6M | -17.2% | $4.9M | 57.4% | $-4,275,000 | -49.9% |
| 2019 | $10.3M | +81.7% | $6.1M | 58.9% | $-3,155,000 | -30.5% |
| 2018 | $5.7M | +49.3% | $3.2M | 56.3% | $-3,016,000 | -53.0% |
| 2017 | $3.8M | +64.2% | $2.3M | 60.2% | $-2,226,000 | -58.4% |
| 2016 | $2.3M | +19.3% | $1.3M | 55.8% | $-2,869,000 | -123.7% |
See NEPH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NEPH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NEPH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNEPH — Frequently Asked Questions
Quick answers to the most common questions about buying NEPH stock.
Is NEPH's revenue growth accelerating or slowing?
NEPH maintains +6.9% revenue growth, in line with its 5-year CAGR of +17.0%. TTM revenue stands at $19M. Growth rate remains consistent with historical average.
What is NEPH's long-term revenue growth rate?
Nephros, Inc.'s 5-year revenue CAGR of +17.0% reflects the sustained expansion pattern. Current YoY growth of +6.9% is near this long-term average.
How is NEPH's revenue distributed by segment?
NEPH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.